Navigation Links
New Poll Shows Strong Support for Conscience Rights in Health Care
Date:4/8/2009

WASHINGTON, April 8 /PRNewswire-USNewswire/ -- A nationwide poll conducted on March 23-25 found that 87 percent of adults surveyed believe it is important to "make sure that healthcare professionals in America are not forced to participate in procedures and practices to which they have moral objections." Conducted by the polling company(TM), inc./WomanTrend on behalf of the Christian Medical Association (CMA), the survey also showed majority support even among self-identified "pro-choice" respondents for the two-month-old conscience protection regulation now at risk of being rescinded by the Department of Health and Human Services (HHS). Deirdre McQuade, spokeswoman on abortion at the U.S. Conference of Catholic Bishops (USCCB), welcomed the data and urged HHS to keep the current regulation in place.

"The Obama administration has moved to rescind a vital HHS regulation protecting the conscience rights of health care providers," McQuade said, "But according to this new survey, the majority of Americans -- whether 'pro-life' or 'pro-choice', male or female, Republican or Democratic -- support the regulation and oppose its rescission."

The survey summary and methodology are available at www.freedom2care.org. The Freedom2Care Coalition is an ad hoc coalition organized by the CMA to defend the conscience rights of health care professionals and students.

The USCCB and Freedom2Care are helping Americans voice their support for the regulations by midnight April 9 when the public comment period draws to a close. To date, a total of over 73,000 e-mail messages have been sent to HHS through Freedom2Care.org and the USCCB's e-mail campaign facilitated by its partner organization, the National Committee for a Human Life Amendment.

"Only one day remains to defend the
'/>"/>

SOURCE U.S. Conference of Catholic Bishops, Secretariat for Pro-Life Activities
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. New study shows promise in reducing surgical risks associated with surgical bleeding
2. New research shows how chronic stress worsens neurodegenerative disease course
3. Embryonic Human Stem Cells May Help Repair Heart Muscle, Lab Study Shows
4. Circulating fats kill transplanted pancreas cells, study shows
5. New Heart Pump Shows Promise in Trial
6. Novel 3-D cell culture model shows selective tumour uptake of nanoparticles
7. New Survey Shows Americans are Still Concerned About Food Safety, Yet Still Not Smart About What They Like to Eat
8. Australian-led international study shows blood pressure drugs cut death rate in type 2 diabetes
9. Amid Improving Life Expectancy Rates, Risk of Premature Death is Still Significant for Americans, New Study Shows
10. Avocados may help prevent oral cancer, OSU study shows
11. New Poll Shows Public Distrusts Flawed Healthcare Approach Favored by Governor and Speaker in AB 8
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... August 29, 2014 Evolutions Medical & ... in the Santa Barbara News-Press Readers’ Choice 2014 poll. ... Readers’ Choice poll as Best Medical Spa. The 2014 ... the following about Evolutions Medical Spa recognition: , “Not ... is recognized as a top-notch, cutting-edge medical spa as ...
(Date:8/29/2014)... August 29, 2014 ReputationChief.Com, a well-established ... named ‘Remove Bad Reviews’. This service has been launched ... account of negative reviews against them. , In order ... to deliver the committed results to its clients, ReputationChief.Com ... the world of internet marketing. , As per the ...
(Date:8/29/2014)... Graduate College of Social Work is the recipient of a ... the National Institute of Drug Abuse (NIDA) at the National ... health consequences of heroin use. Additionally, the grant provides resources ... , Heroin use has increased steadily since 2007 ... abuse to the cheaper and more available opioid. , ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 "After reading a ... don’t stand very often, I decided that there needed to ... during the day," said a concerned inventor from Sikestons, Mo. ... for long periods. It builds endurance and keeps the user ... health. Easy to use and producible in design variations, it's ...
(Date:8/29/2014)... hospitalized for a burn as a child experience higher than ... research at the University of Adelaide . , A ... by the University,s Centre for Traumatic Stress Studies. They ... of mental illness and 30% suffered depression at some stage ... journal Burns , also found that long-term ...
Breaking Medicine News(10 mins):Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 2Health News:Evolutions Named Best Medical Spa in Santa Barbara by Santa Barbara News Press 3Health News:ReputationChief.Com Announces a New Service ‘Remove Bad Reviews’ 2Health News:$1.25 million NIH grant to aid research on impact of heroin use 2Health News:Intervention needed for survivors of childhood burns 2
... you were at high risk of cancer because you carry ... A recent study at Fox Chase Cancer Center not only ... level and studied the parent perceptions of the impact of ... at the 2009 Annual Meeting of the American Society of ...
... study of targeted educational initiatives between the clinical staff ... their Partners program suggest that educational interventions by academic ... patients at community hospitals. The study, to be ... Society of Clinical Oncology, looked specifically at the number ...
... 14, 2009)Researchers at Fox Chase Cancer Center uncovered a ... tumor (GIST) patients respond to the targeted therapy imatinib ... that could be suppressed in order to make these ... PhD, a postdoctoral fellow in the laboratory of Andrew ...
... guide important treatment decisions, experts say , , THURSDAY, May ... at predicting colon cancer recurrence may help individualize treatment ... therapy choices, scientists say. , The Oncotype DX test ... more likely to have a recurrence and which were ...
... of new pharmaceutical products in the pipeline combined with ... for the rare disease community, a senior Food and ... hosted by the National Organization for Rare Disorders (NORD).The ... MD, director of the Center for Drug Evaluation and ...
... proteomic test as a predictor of overall survival benefit ... VeriStrat, a blood-based, proteomic test currently used for patients ... presented by Christine Chung, MD, Assistant Professor of Medicine ... at the 45th Annual Meeting of the American Society ...
Cached Medicine News:Health News:Should parents share the results of BRCA1/2 genetic testing with their children? 2Health News:Educational initiatives improve quality of care delivery 2Health News:Gene signature may predict patient response to therapy for gastrointestinal stromal tumors 2Health News:Gene Screen May Predict Colon Cancer's Return 2Health News:Gene Screen May Predict Colon Cancer's Return 3Health News:NORD Sponsors Rare Disease Summit 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 2Health News:May 14, 2009: Biodesix Announces VeriStrat(R) Data in Head and Neck Cancer to be Presented at ASCO 3
(Date:8/28/2014)... Takeda Pharmaceutical Company Limited ("Takeda") today announced ... of data from a 10-year epidemiology study to ... (U.S.) Food and Drug Administration (FDA), ... Ministry of Health, Labour, and Welfare (MHLW) / ... for pioglitazone containing medicines, including ACTOS (pioglitazone HCl). ...
(Date:8/28/2014)... , Aug. 28, 2014  In anticipation of the upcoming ... being made available for the first time. Industry Overview: ... offers a snapshot of San Diego,s ... Highlighting everything from the latest employment statistics to current venture ... San Diego such a vital part of ...
(Date:8/28/2014)... /PRNewswire-iReach/ -- Academy Leadership, an elite leadership training firm ... a case study highlighting one manager,s experience ... In September and October 2014, Academy Leadership affiliates are ... , Indianapolis , Salt Lake City , ... http://photos.prnewswire.com/prnh/20140828/140814 Leadership training for managers ...
Breaking Medicine Technology:Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 2Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 3Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 4Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 5Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS 6New Infographic Published - Overview of Medtech & Life Sciences Industry in San Diego 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 2Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 3Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 4Academy Leaders Publishes Case Study on Work with Global Pharmaceutical Company 5
... , FRIMLEY, England, December 8 ... Measures of Treatment Effectiveness,in the Trial, in Patients With Newly-Diagnosed Disease(1) , ... Later Stages,of the Disease on nilotinib (300mg Twice-Daily and 400mg Twice-Daily) Than ... Well Tolerated; Only a Small Number of Patients,Discontinued Due to Adverse Events(1) ...
... Micromet, Inc. (Nasdaq: MITI ), a biopharmaceutical ... cancer, inflammation and autoimmune diseases, today announced data from ... patients with B-precursor acute lymphoblastic leukemia (ALL). The data ... Annual Meeting of the American Society of Hematology (ASH) ...
Cached Medicine Technology:Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 2Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 3Final Data from Phase 2 Study Confirm High Response Rate of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia 4
... (tTg) is a ubiquitous enzyme that ... transglutaminase is also the specific protein ... antibody immunofluorescence (EMA) tests (Bio-Rad catalog ... and,IgG serologic tests are highly sensitive ...
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
We offer small and large pre-gelled Surface Electrodes suitable for EMG or EGG recordings....
Medicine Products: